Literature DB >> 17593071

Generation of dyspeptic symptoms by direct acid infusion into the stomach of healthy Japanese subjects.

H Miwa1, K Nakajima, K Yamaguchi, K Fujimoto, S J O Veldhuyzen VAN Zanten, Y Kinoshita, K Adachi, H Kusunoki, K Haruma.   

Abstract

OBJECTIVE: The relationship between acid and dyspeptic symptoms has not been fully understood. AIM: To investigate the type and severity of dyspeptic symptoms induced by direct acid infusion into the stomach of Japanese healthy subjects.
METHODS: This was a multi-centre, cross-over, randomized, double-blind study in 27 healthy subjects (mean age 27). Each fasted subject received two tests with 150 mL of 0.1 mol/L hydrochloric acid infusion (15 mL/min for 10 min) and the same volume of pure water infusion. The type and severity of symptoms were assessed by a 10 cm visual analogue scale administered every 2 min up to 30 min.
RESULTS: Various symptoms were reported after both acid and water infusions. Most of the symptoms were more severe after acid infusion compared with water infusion (acid vs. water: discomfort 1.8 +/- 0.4 vs. 0.5 +/- 0.1, pain 0.6 +/- 0.3 vs. 0.1 +/- 0.1, reflux 1.0 +/- 0.3 vs. 0.3 +/- 0.1 and satiety 1.1 +/- 0.4 vs. 0.2 +/- 0.1). The area under curve for dysmotility like symptoms (heavy feeling in the stomach, bloating, nausea or feeling sick, and belching) was significantly higher in acid infusion, and symptoms continued after infusion of the acid.
CONCLUSION: Acid induced into stomach induced dysmotility-like predominant dyspeptic symptoms in Japanese healthy control subjects, demonstrating the possible importance of acid in symptom generation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17593071     DOI: 10.1111/j.1365-2036.2007.03367.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  28 in total

1.  Real-time evaluation of dyspeptic symptoms and gastric motility induced by duodenal acidification using noninvasive transnasal endoscopy.

Authors:  Manabu Ishii; Noriaki Manabe; Hiroaki Kusunoki; Tomoari Kamada; Motonori Sato; Hiroshi Imamura; Akiko Shiotani; Jiro Hata; Ken Haruma
Journal:  J Gastroenterol       Date:  2008-12-24       Impact factor: 7.527

2.  Clinical characteristics and effectiveness of lansoprazole in Japanese patients with gastroesophageal reflux disease and dyspepsia.

Authors:  Yoshikazu Kinoshita; Hiroto Miwa; Katsuyuki Sanada; Koji Miyata; Ken Haruma
Journal:  J Gastroenterol       Date:  2013-05-08       Impact factor: 7.527

3.  Inhibition of gastric perception of mild distention by omeprazole in volunteers.

Authors:  Akihito Iida; Hiroshi Kaneko; Toshihiro Konagaya; Yasushi Funaki; Kentaro Tokudome; Shinya Izawa; Yasuhiro Tamura; Mari Mizuno; Naotaka Ogasawara; Makoto Sasaki; Kunio Kasugai
Journal:  World J Gastroenterol       Date:  2012-10-21       Impact factor: 5.742

4.  Proton pump inhibitor monotherapy is effective to attenuate dyspepsia symptoms associated with gastroesophageal reflux disease: a multicenter prospective observational study.

Authors:  Kimio Isshi; Nobuyuki Matsuhashi; Takashi Joh; Kazuhide Higuchi; Katsuhiko Iwakiri; Takeshi Kamiya; Noriaki Manabe; Maiko Ogawa; Seiji Arihiro; Ken Haruma; Koji Nakada
Journal:  J Gastroenterol       Date:  2019-01-23       Impact factor: 7.527

Review 5.  Visceral hypersensitivity and electromechanical dysfunction as therapeutic targets in pediatric functional dyspepsia.

Authors:  John M Rosen; Jose T Cocjin; Jennifer V Schurman; Jennifer M Colombo; Craig A Friesen
Journal:  World J Gastrointest Pharmacol Ther       Date:  2014-08-06

6.  Evidence-based clinical practice guidelines for functional dyspepsia.

Authors:  Hiroto Miwa; Motoyasu Kusano; Tomiyasu Arisawa; Tadayuki Oshima; Mototsugu Kato; Takashi Joh; Hidekazu Suzuki; Kazunari Tominaga; Koji Nakada; Akihito Nagahara; Seiji Futagami; Noriaki Manabe; Akio Inui; Ken Haruma; Kazuhide Higuchi; Koji Yakabi; Michio Hongo; Naomi Uemura; Yoshikazu Kinoshita; Kentaro Sugano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2015-01-14       Impact factor: 7.527

7.  Therapeutic effects of famotidine on chronic symptomatic gastritis: subgroup analysis from FUTURE study.

Authors:  Yoshikazu Kinoshita; Tsutomu Chiba
Journal:  J Gastroenterol       Date:  2011-12-21       Impact factor: 7.527

8.  Gastric hypochlorhydria is associated with an exacerbation of dyspeptic symptoms in female patients.

Authors:  Wataru Iwai; Yasuhiko Abe; Katsunori Iijima; Tomoyuki Koike; Kaname Uno; Naoki Asano; Akira Imatani; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2012-07-25       Impact factor: 7.527

9.  Comparison of PPIs and H2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia.

Authors:  Masahiro Sakaguchi; Miyuki Takao; Yasuo Ohyama; Hiroshi Oka; Hiroshi Yamashita; Takumi Fukuchi; Kiyoshi Ashida; Masahiro Murotani; Masuyo Murotani; Kazuo Majima; Hiroshi Morikawa; Takashi Hashimoto; Keisuke Kiyota; Hirohiko Esaki; Kanji Amemoto; Gouhei Isowa; Fumiyuki Takao
Journal:  World J Gastroenterol       Date:  2012-04-07       Impact factor: 5.742

10.  Comparison of the effects of omeprazole and famotidine in treatment of upper abdominal symptoms in patients with reflux esophagitis.

Authors:  Hiroaki Kusunoki; Masayasu Kusaka; Soichiro Kido; Ryo Yamauchi; Yoshinori Fujimura; Yasuyuki Watanabe; Michio Kobori; Hiroto Miwa; Toshihiko Tomita; Yongmin Kin; Kazutoshi Hori; Nobuo Tano; Kenji Sugimoto; Yoshihiro Nakamura; Kazuma Fujimoto; Noriko Oza; Aki Matsunobu; Naofumi Ono; Seisuke Fuyuno; Yoshikazu Kinoshita; Kyoichi Adachi; Mika Yuki; Tomoo Fujisawa; Ken Haruma
Journal:  J Gastroenterol       Date:  2009-03-13       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.